Alliance Global Partners Maintains Buy on DarioHealth, Lowers Price Target to $4.1
Alliance Global Partners Maintains Buy on DarioHealth, Lowers Price Target to $4.1
Alliance Global Partners維持對DarioHealth的買入，將目標股
Alliance Global Partners analyst Ben Haynor maintains DarioHealth (NASDAQ:DRIO) with a Buy and lowers the price target from $5.45 to $4.1.
Alliance Global Partners分析師Ben Haynor維持DarioHealth(納斯達克：DIO)的買入評級，並將目標價從5.45美元下調至4.1美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。